{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:50:55Z","timestamp":1779281455143,"version":"3.51.4"},"reference-count":22,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Division of Pathology and Laboratory Medicine, the University of Texas MD Anderson Cancer Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Blastoid B-cell neoplasms mainly include B-lymphoblastic leukemia\/lymphoma (B-ALL), blastoid mantle cell lymphoma, and high-grade B-cell lymphoma with blastoid morphologic features (blastoid HGBL). Distinguishing blastoid HGBL from B-ALL can be challenging and we previously developed six-point flow cytometry-focused and three-point immunohistochemistry-focused scoring systems to aid in differential diagnosis. However, the six-point scoring system was derived from bone marrow cases and occasional cases may have a misleading score using either system. In this study, we assessed 121 cases of blastoid-HGBL (37 BM and 84 extramedullary) to validate the six-point scoring system in all tissue types and to further compare the two scoring systems. Compared with 47 B-ALL cases enriched for CD34-negative neoplasm, the 121 blastoid-HGBL cases showed distinctive pathologic features. The six-point scoring system showed a sensitivity of 100%. A comparison of the two scoring systems in blastoid HGBL (n = 64) and B-ALL (n = 37) showed a concordance score rate of 88%. Thirteen cases showed misleading scores, including five HGBL and eight B-ALL, and the diagnosis was further validated by gene transcriptome profiling. Twelve of thirteen cases had discordant scores between the two scoring systems. Simultaneous employment of both scoring systems improved the accuracy of classification of blastoid B-cell neoplasms to 99%. In conclusion, the previously defined six-point scoring system showed an excellent performance regardless of the tissue origin. Using both scoring systems together improves the accuracy of classification of blastoid B-cell neoplasms. Cases with discordant scores between the two scoring systems were extremely challenging neoplasms and classification required correlation with all available clinical and genetic features.<\/jats:p>","DOI":"10.3390\/cancers15030848","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:19:53Z","timestamp":1675077593000},"page":"848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-4587","authenticated-orcid":false,"given":"Lianqun","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA 98115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-4128","authenticated-orcid":false,"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-6943","authenticated-orcid":false,"given":"Mahsa","family":"Khanlari","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN 38105, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-0523","authenticated-orcid":false,"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41379-018-0112-9","article-title":"High-grade B-cell lymphomas with TdT expression: A diagnostic and classification dilemma","volume":"32","author":"Ok","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PAS.0000000000001750","article-title":"Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity","volume":"46","author":"Bhavsar","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Uchida, A., Isobe, Y., Uemura, Y., Nishio, Y., Sakai, H., Kato, M., Otsubo, K., Hoshikawa, M., Takagi, M., and Miura, I. (2017). De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements: A case report and literature review. BMC Clin. Pathol., 17.","DOI":"10.1186\/s12907-017-0060-1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41379-021-00909-4","article-title":"Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: A diagnostic challenge","volume":"35","author":"Khanlari","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Qiu, L., Xu, J., Lin, P., Cohen, E.N., Tang, G., Wang, S.A., Khanlari, M., Wang, W., Khoury, J.D., and Konoplev, S. (2022). Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B acute lymphoblastic leukemia\/lymphoma. Haematologica.","DOI":"10.3324\/haematol.2022.281646"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41379-018-0067-x","article-title":"MYC\/BCL2\/BCL6 triple hit lymphoma: A study of 40 patients with a comparison to MYC\/BCL2 and MYC\/BCL6 double hit lymphomas","volume":"31","author":"Huang","year":"2018","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/modpathol.2015.66","article-title":"Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies","volume":"28","author":"Yin","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000516654","article-title":"International System for Human Cytogenetic or Cytogenomic Nomenclature (ISCN): Some Thoughts","volume":"161","author":"Liehr","year":"2021","journal-title":"Cytogenet. Genome Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/modpathol.2017.93","article-title":"Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"30","author":"Quesada","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3324\/haematol.2013.093765","article-title":"Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: Applicability for diagnostics and disease monitoring","volume":"99","author":"Luthra","year":"2014","journal-title":"Haematologica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1016\/j.celrep.2019.11.078","article-title":"Comparison of Reproducibility, Accuracy, Sensitivity, and Specificity of miRNA Quantification Platforms","volume":"29","author":"Godoy","year":"2019","journal-title":"Cell Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113041","DOI":"10.1016\/j.jim.2021.113041","article-title":"Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy","volume":"494","author":"Zhang","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clml.2014.01.004","article-title":"Extramedullary B lymphoblastic leukemia\/lymphoma (B-ALL\/B-LBL): A diagnostic challenge","volume":"14","author":"Geethakumari","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.ajpath.2016.07.027","article-title":"B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains","volume":"186","author":"Slot","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ajcp\/aqaa126","article-title":"Simultaneous Discordant B-Lymphoblastic Lymphoma and Follicular Lymphoma","volume":"155","author":"Fujimoto","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000818","article-title":"Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid Morphology","volume":"41","author":"Moore","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_18","first-page":"e21261","article-title":"Frequency of CD34 and CD10 Expression in Adolescent and Young Adult Patients Having Precursor B-cell Acute Lymphoblastic Leukemia and Its Correlation With Clinical Outcomes: A Single-Center Study","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.31557\/APJCP.2021.22.3.919","article-title":"CD34 is not Expressed by Blasts in a Third of B-ALL Patients and its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis","volume":"22","author":"Garg","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3109\/10428194.2016.1141407","article-title":"B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: Report of five new cases and review of the literature","volume":"57","author":"Sajaroff","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1309\/AJCPAN7BH5DNYWZB","article-title":"B-acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"144","author":"Loghavi","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1309\/AJCPO4U4VYAAOTEL","article-title":"BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia","volume":"143","author":"Deucher","year":"2015","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:19:42Z","timestamp":1760120382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15030848"],"URL":"https:\/\/doi.org\/10.3390\/cancers15030848","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}